Literature DB >> 17211433

Cytogenetic evolution patterns in CML post-SCT.

K Karrman1, B Sallerfors, S Lenhoff, T Fioretos, B Johansson.   

Abstract

The cytogenetic evolution patterns in chronic myeloid leukemia (CML) after allogeneic (allo) stem cell transplantation (SCT) are different from the ones observed in non-transplanted patients, a phenomenon suggested to be caused by the conditioning regime. We reviewed 131 CMLs displaying karyotypic evolution after SCT (122 allo, nine autologous (auto)), treated at Lund University Hospital or reported in the literature. Major route abnormalities (i.e., +8, +Ph, i(17q), +19, +21, +17 and -7) were seen in 14%, balanced aberrations in 61%, hyperdiploidy in 19%, pseudodiploidy in 79%, divergent clones in 14%, and Ph-negative clones in 21%. The breakpoints involved in secondary structural rearrangements clustered at 1q21, 1q32, 7q22, 9q34, 11q13, 11q23, 12q24, 13q14, 17q10 and 22q11. Cytogenetic abnormalities common in AML after genotoxic exposure, that is, der(1;7)(q10;p10), del(3p), -5, del(5q), -7, -17, der(17p), -18, and -21, were only rarely seen post-SCT. Comparing the cytogenetic features in relation to type of SCT revealed that balanced aberrations were significantly more common after allo than after auto SCT (64 and 22%, respectively, P=0.03). In addition, there was a trend as regards hyperdiploidy being more common after auto (P=0.07) and pseudodiploidy being more frequent after allo SCT (P=0.09). Possible reasons for these differences are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17211433     DOI: 10.1038/sj.bmt.1705560

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

1.  RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity.

Authors:  Sonia Cellot; Kristin J Hope; Jalila Chagraoui; Martin Sauvageau; Éric Deneault; Tara MacRae; Nadine Mayotte; Brian T Wilhelm; Josette R Landry; Stephen B Ting; Jana Krosl; Keith Humphries; Alexander Thompson; Guy Sauvageau
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

2.  Karyotypic findings in chronic myeloid leukemia cases undergoing treatment.

Authors:  Anupam Kaur; Simran Preet Kaur; Amarjit Singh; Jai Rup Singh
Journal:  Indian J Hum Genet       Date:  2012-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.